These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2072413)

  • 1. p53 in the diagnosis of human neoplasia.
    Cossman J; Schlegel R
    J Natl Cancer Inst; 1991 Jul; 83(14):980-1. PubMed ID: 2072413
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cancer mutations and normal cell regulation].
    Fredholm BB
    Lakartidningen; 1992 Oct; 89(43):3568, 3571-2. PubMed ID: 1460965
    [No Abstract]   [Full Text] [Related]  

  • 3. The p53 tumour suppressor gene and product.
    Levine AJ
    Cancer Surv; 1992; 12():59-79. PubMed ID: 1638548
    [No Abstract]   [Full Text] [Related]  

  • 4. The 1995 Walter Hubert Lecture--molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene.
    Harris CC
    Br J Cancer; 1996 Feb; 73(3):261-9. PubMed ID: 8562328
    [No Abstract]   [Full Text] [Related]  

  • 5. Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry.
    Nenutil R; Smardova J; Pavlova S; Hanzelkova Z; Muller P; Fabian P; Hrstka R; Janotova P; Radina M; Lane DP; Coates PJ; Vojtesek B
    J Pathol; 2005 Nov; 207(3):251-9. PubMed ID: 16161005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53: balancing tumour suppression and implications for the clinic.
    Buganim Y; Rotter V
    Eur J Cancer; 2009 Sep; 45 Suppl 1():217-34. PubMed ID: 19775621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Looking at p53: theoretical implications and methodological aspects.
    Opalka B; Kasimir-Bauer S
    Arch Toxicol Suppl; 1997; 19():17-28. PubMed ID: 9079191
    [No Abstract]   [Full Text] [Related]  

  • 8. To pop or not to pop: p53 as a critical modulator of tumour responsiveness to therapy in vivo?
    Workman P
    Hum Exp Toxicol; 1995 Feb; 14(2):222-5. PubMed ID: 7779451
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting mutant p53 for cancer therapy.
    Oren M; Tal P; Rotter V
    Aging (Albany NY); 2016 Jun; 8(6):1159-60. PubMed ID: 27347904
    [No Abstract]   [Full Text] [Related]  

  • 10. p53--master and commander.
    Foulkes WD
    N Engl J Med; 2007 Dec; 357(25):2539-41. PubMed ID: 18094374
    [No Abstract]   [Full Text] [Related]  

  • 11. [Environmental carcinogens and p53 gene mutation].
    Xu Z; Jin Y
    Wei Sheng Yan Jiu; 2004 Mar; 33(2):239-43. PubMed ID: 15209018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma.
    Liu XF; Zhang H; Zhu SG; Zhou XT; Su HL; Xu Z; Li SJ
    World J Gastroenterol; 2006 Aug; 12(29):4706-9. PubMed ID: 16937443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible association of p53 overexpression and mutation with high-grade chondrosarcoma.
    Dobashi Y; Sugimura H; Sato A; Hirabayashi T; Kanda H; Kitagawa T; Kawaguchi N; Imamura T; Machinami R
    Diagn Mol Pathol; 1993 Dec; 2(4):257-63. PubMed ID: 8118603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the origins of tumor mutations in cancer genes: insights from the p53 gene.
    Hollstein M; Moeckel G; Hergenhahn M; Spiegelhalder B; Keil M; Werle-Schneider G; Bartsch H; Brickmann J
    Mutat Res; 1998 Sep; 405(2):145-54. PubMed ID: 9748548
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutations of the p53 gene in human functional adrenal neoplasms.
    Lin SR; Lee YJ; Tsai JH
    J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [P53 protein: a new tool for the clinician?].
    Laurent-Puig P
    Gastroenterol Clin Biol; 1995 May; 19(5):463-4. PubMed ID: 7589996
    [No Abstract]   [Full Text] [Related]  

  • 17. Methods for screening tumors for p53 status and therapeutic exploitation.
    Tullo A; D'Erchia AM; Sbisà E
    Expert Rev Mol Diagn; 2003 May; 3(3):289-301. PubMed ID: 12779005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the expression of the p53 protein in human cancer.
    Lane DP
    Mol Biol Rep; 1994 Jan; 19(1):23-9. PubMed ID: 8170465
    [No Abstract]   [Full Text] [Related]  

  • 19. The expanding universe of p53 targets.
    Menendez D; Inga A; Resnick MA
    Nat Rev Cancer; 2009 Oct; 9(10):724-37. PubMed ID: 19776742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations.
    Matsushima AY; Cesarman E; Chadburn A; Knowles DM
    Am J Pathol; 1994 Mar; 144(3):573-84. PubMed ID: 8129043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.